Inhibiting IDO pathways to treat cancer: lessons from the ECHO-301 trial and beyond.
- Published in:
- Seminars in Immunopathology, 2019, v. 41, n. 1, p. 41, doi. 10.1007/s00281-018-0702-0
- By:
- Publication type:
- Article
Works matching IS 18632297 AND DT 2019 AND VI 41 AND IP 1
Results: 12
1
2
Developing combination strategies using PD-1 checkpoint inhibitors to treat cancer.
- Published in:
- Seminars in Immunopathology, 2019, v. 41, n. 1, p. 21, doi. 10.1007/s00281-018-0714-9
- By:
- Publication type:
- Article
3
Off-the-shelf cell therapy with induced pluripotent stem cell-derived natural killer cells.
- Published in:
- Seminars in Immunopathology, 2019, v. 41, n. 1, p. 59, doi. 10.1007/s00281-018-0721-x
- By:
- Publication type:
- Article
4
Principles of adoptive T cell therapy in cancer.
- Published in:
- Seminars in Immunopathology, 2019, v. 41, n. 1, p. 49, doi. 10.1007/s00281-018-0703-z
- By:
- Publication type:
- Article
5
Anti-cancer immunotherapy: breakthroughs and future strategies.
- Published in:
- Seminars in Immunopathology, 2019, v. 41, n. 1, p. 1, doi. 10.1007/s00281-018-0711-z
- By:
- Publication type:
- Article
6
Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?
- Published in:
- Seminars in Immunopathology, 2019, v. 41, n. 1, p. 5, doi. 10.1007/s00281-018-0700-2
- By:
- Publication type:
- Article
7
Does patient age influence anti-cancer immunity?
- Published in:
- Seminars in Immunopathology, 2019, v. 41, n. 1, p. 125, doi. 10.1007/s00281-018-0697-6
- By:
- Publication type:
- Article
8
Cancer immune therapy for lymphoid malignancies: recent advances.
- Published in:
- Seminars in Immunopathology, 2019, v. 41, n. 1, p. 111, doi. 10.1007/s00281-018-0696-7
- By:
- Publication type:
- Article
9
The T-win® technology: immune-modulating vaccines.
- Published in:
- Seminars in Immunopathology, 2019, v. 41, n. 1, p. 87, doi. 10.1007/s00281-018-0695-8
- By:
- Publication type:
- Article
10
Cancer immune therapy for myeloid malignancies: present and future.
- Published in:
- Seminars in Immunopathology, 2019, v. 41, n. 1, p. 97, doi. 10.1007/s00281-018-0693-x
- By:
- Publication type:
- Article
11
Acquired resistance to cancer immunotherapy.
- Published in:
- Seminars in Immunopathology, 2019, v. 41, n. 1, p. 31, doi. 10.1007/s00281-018-0692-y
- By:
- Publication type:
- Article
12
Therapeutic cancer vaccine: building the future from lessons of the past.
- Published in:
- Seminars in Immunopathology, 2019, v. 41, n. 1, p. 69, doi. 10.1007/s00281-018-0691-z
- By:
- Publication type:
- Article